Lifecore Biomedical, Inc. (LFCR)
NASDAQ: LFCR · Real-Time Price · USD
5.12
+0.04 (0.79%)
Apr 28, 2026, 4:00 PM EDT - Market closed

Lifecore Biomedical Revenue

In the year 2025, Lifecore Biomedical had annual revenue of $129.46M with 0.46% growth. Lifecore Biomedical had revenue of $35.75M in the quarter ending December 31, 2025, with 9.77% growth.

Revenue (ttm)
$129.46M
Revenue Growth
+0.79%
P/S Ratio
1.48
Revenue / Employee
$338,913
Employees
382
Market Cap
191.88M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2025129.46M597.59K0.46%
May 25, 2025128.87M606.00K0.47%
May 26, 2024128.26M24.99M24.20%
May 28, 2023103.27M-8.00M-7.19%
May 29, 2022111.27M10.40M10.31%
May 30, 2021 Pro Pro Pro
May 31, 2020 Pro Pro Pro
May 26, 2019 Pro Pro Pro
May 27, 2018 Pro Pro Pro
May 28, 2017 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Organogenesis Holdings 564.17M
Evolus 297.18M
Aurora Cannabis 272.13M
Akebia Therapeutics 236.20M
Organigram Global 204.21M
Assertio Holdings 118.71M
Anika Therapeutics 112.82M
SIGA Technologies 94.57M
Revenue Rankings